Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
i hear you, but why would Dart let something like this happen to him? he's smarter than that. that's what i don't understand
sk needs to step it up and stop the bs already, sell or partner up
awesome close
and how do you know all of this
maybe they are looking to make a run here
wow our pphm can't get any traction, market up and we are down, what a surprise
don't forget, "warrant free" ATM
voted against all those jerkoffs on the board
who's with me
please elaborate what you are referring to...
The following table shows the per share and total cash placement agent’s fees we will pay to the placement agent in connection with the sale of the shares offered pursuant to this prospectus supplement and the related prospectus assuming the purchase of all of the shares offered hereby:
Per Share $0.0666
Total $416,399.98
We have agreed to pay McNicoll, Lewis and Vlak a fee of $138,750 and LifeTech Capital a fee of $24,990 in connection with this offering.
IMO, they did this offering simply to fulfill obligated payments for services rendered.
jonnyrocket, do you follow these guys on twitter?
BioRunUp
@BioRunUp BioRunUp
$PPHM - Results give a big headline but the study was not a randomized or controlled, so really means nothing. #JUNK
14 minutes ago via TweetDeck
BioRunUp
@BioRunUp BioRunUp
Times like this $PPHM PR, I really miss @adamfeuerstein :)
Yes, that maybe news that was dug up by shareholders. The company didn't think it was worthwhile to let anybody know
The lack of news over the last couple of months is a bit disheartening
it's there
Sep 7–9, 2011 Stifel Nicolaus Healthcare Conference, Boston MA
Reminder Remind me
Show Additional Information
there is also this
Afternoon of
Sep 27, 2011
12:00 PM ET JMP Securities Healthcare Conference
Reminder Remind me
Show Additional Information
OS as of today is what?
raise your hand if you think PPHM was pushed down so somebody or some entity was able to buy cheap shares.
i know half will think yes, and half will think no
buysellshort.net
$PPHM breakout here $1.35, $1.53 20 day EMA 1st target
19 minutes ago
big deal, then they just knock it down again
where are the insider buys for this POS?? obviously management doesn't even want to own PPHM!
i do not think they are atm trades, more likely market makers squaring off trades from the day
this is a joke, once again pure manipulation, yea yea i know some of you don't think so but this surely is
no support whatsoever...
you see them take it down to 1.99 on literally no volume, all market makers 100 share lots to take it down, but no shorts covered, no volume, this trades like it is on the pink sheets
PPHM must have gotten a larger percentage in the Russell thus causing end of day buying...IMO
option related??
@adamfeuersteinAdam Feuerstein, is such a tool, we all know PPHM is better than avastin
woohoo we got a break out
THIS IS PATHETIC
IGI Market Perform target 1.50
Grisewood, CFA, Senior Analyst on IGI Laboratories, Inc. Grisewood establishes a Market Perform rating on the stock, with a 12-month target of $1.50
http://www.tripointglobalresearch.com/research/IG/IG_Report_052511.pdf
Sherry Grisewood, CFA
Ms. Grisewood has over 25 years experience in a range of investment banking and research-related activities. In addition to being an independent strategic and financial advisor, she has also served as a Senior Life Sciences Banker at Jesup & Lamont Securities Corp and as Director of Research/Special Situations Analyst for several mid-tier brokerage companies and a independent on-line investment research company. As an independent advisor and consultant, Sherry has completed extensive research due diligence, competitive intelligence, and business evaluation projects for corporate and investment bank clients, as well as successfully negotiated acquisitions and other strategic transactions between private companies and public companies. The primary focus of these activities is advanced technologies in the life sciences and alternative energy.
In addition to research activities, Ms. Grisewood has published daily market commentary for over 10 years and was a regular commentator on Wall Street Journal Radio until 2004. Sherry holds a Bachelor of Science degree (Highest Honors) in Life Science from Ramapo College of New Jersey and achieved the Chartered Financial Analyst designation in 1990 and is a member of the CFA Institute, NY Society of Security Analysts, and an individual member of the European Federation of Biotechnology, the Tissue Engineering and Regenerative Medicine Society International, the Society of Biomaterials and the American Society of Gene Therapy.
@bman_microcaps knows his $hit
they did it again, killed a nice little run
thank you, so where do we go from here? constant manipulation that others deny all the time. it is evident that it is being manipulated. would pphm want it this way or is it another force?
pphm again, what a joke, goes down on mostly 100 share lots, we better see a filing from dart or one of his friends at this point
eastern capital (dart) not on that list??
stops will be taken out
It's Blackrock, yes the real deal
/s/ Robert W. Doll, Jr.
Name: Robert W. Doll, Jr.
Title: Vice Chairman
wow, a response, good to know they publicized the fact that garovoy was not there anymore
maybe we are turning around
yup..agreed
if thats what you really want to believe. i really doubt it. the trading in the stock has changed since we hit the 3.09. it was tradng like a stock that was not trying to be manipulated down. now its biz as usual...sad
100 share lots being sold and bought is not manipulation?? who the f*ck buys or sells 100 shares? really
the issue is he WAS listed on the PPHM website as a member of the management team